Soft Tissue Biologics Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Soft Tissue Biologics Pipeline Market Report Overview
Soft Tissue Biologics are used in surgical procedures to replace, reinforce, or repair tendons or ligaments that have been torn or damaged in the human body. This model focuses on the repair of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), rotator cuff, and Achilles tendon. Other indications include medial collateral ligament (MCL), lateral collateral ligament (LCL), medial patellofemoral ligament (MPFL), ulnar collateral ligament (UCL), flexor tendon, and hip flexor repair. They can be either tendon grafts/reinforcements or tendon wrapping products.
Key Segments | · Synthetic Graft
· Xerograft · Collagen |
Key Territories | · The US
· China · Europe · Vietnam · Malaysia · Philippines · Singapore |
Key Regulatory Paths | · 510(k)
· NMPA · CE · HAS · MDA · BLA |
Leading Companies | · Acuitive Technologies Inc
· Anika Therapeutics Inc · BioGend Therapeutics Co Ltd · Colorado Therapeutics, LLC · Columbia University · Core Essence Orthopaedics, LLC · Georgia Institute of Technology |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Soft Tissue Biologics Pipeline Market by Segments
The key segments in the soft tissue biologics pipeline market are Synthetic Graft, Xerograft, and Collagen. As of August 2023, Synthetic Graft has the highest number of pipeline products.
Soft Tissue Biologics Pipeline Market Analysis by Segments, 2023 (%)
Buy Full Report for More Insights into the Soft Tissue Biologics Pipeline Market Segments or Download a Free Sample Report
Soft Tissue Biologics Pipeline Market Segmentation by Territories
Some of the key territories in the Soft Tissue Biologics Pipeline Market are the US, China, Europe, Vietnam, Malaysia, Philippines, and Singapore. As of August 2023, the US has the highest number of pipeline products.
Soft Tissue Biologics Pipeline Market Analysis by Territories, 2023 (%)
Buy Full Report for More Territory Insights into the Soft Tissue Biologics Pipeline Market
Download a Free Sample Report
Soft Tissue Biologics Pipeline Market Segmentation by Regulatory Paths
Some of the key regulatory paths in the Soft Tissue Biologics pipeline market are 510(k), NMPA, CE, HAS, MDA, and BLA. As of August 2023, 510(k) is the most followed path for pipeline products in the market.
Soft Tissue Biologics Pipeline Market Analysis by Regulatory Paths, 2023 (%)
Buy Full Report for More Regulatory Path Insights into the Soft Tissue Biologics Pipeline Market or
Download a Free Sample Report
Soft Tissue Biologics Pipeline Market – Competitive Landscape
Some of the key companies in the Soft Tissue Biologics pipeline market are Acuitive Technologies Inc, Anika Therapeutics Inc, BioGend Therapeutics Co Ltd, Colorado Therapeutics, LLC, Columbia University, Core Essence Orthopaedics, LLC, Georgia Institute of Technology among others
Anika Therapeutics Inc: It offers solutions for ortho-biologics, dermal, ophthalmic, surgical, and veterinary applications. Its major products include human and veterinary visco-supplementation, Joint implants, instrumentation devices, joint replacement solutions, regenerative and orthopedic surgical therapies, bone repair therapy, advanced wound care, and ophthalmic products. Its products are made from hyaluronic acid (HA) based on technology, HYAFF, which is a solid form of HA.
Columbia University: CU conducts research through its research institutes and centers in the areas of natural and bio-medical sciences, social sciences, and humanities. Meanwhile, the university provides educational services and courses through its schools, departments, faculties, centers, and institutes. It also provides undergraduate and graduate courses in various disciplines including architecture, planning and preservation, arts, sciences, social sciences, dental medicine, engineering, law, social work, nursing and public health, among others.
Soft Tissue Biologics Pipeline Market Analysis by Companies, 2023
Buy Full Report for More Insights into the Leading Companies in the Soft Tissue Biologics Pipeline Market
Download a Free Sample Report
Segments Covered in the Report
Soft Tissue Biologics Pipeline Market Segments Outlook
- Synthetic Graft
- Xenograft
- Collagen
Soft Tissue Biologics Pipeline Market Territories Outlook
- The US
- China
- Europe
- Vietnam
- Malaysia
- Philippines
- Singapore
Soft Tissue Biologics Pipeline Market Regulatory Paths Outlook
- 510(k)
- NMPA
- CE
- HSA
- MDA
- BLA
Scope
This report provides:
- Extensive coverage of the Soft Tissue Biologics under development.
- The report reviews details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
- The report reviews the major players involved in the development of Soft Tissue Biologics and lists all their pipeline projects.
- The coverage of pipeline products is based on various stages of development ranging from early development to approved/issued stage.
- The report provides key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of Soft Tissue Biologics under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date
Anika Therapeutics Inc
BioGend Therapeutics Co Ltd
Colorado Therapeutics, LLC
Columbia University
Core Essence Orthopaedics, LLC
Georgia Institute of Technology
New York R&D Center for Translational Medicine and Therapeutics Inc
Novadip Biosciences SA
Nutech Medical Inc
OHSU Knight Cancer Institute
Osteopore International Pte Ltd
Shandong Junxiu Biotechnology Co Ltd
STEL Technologies LLC
Tissue Regenix Group PLC
University of Bielefeld
University of Minnesota
University of Missouri
Table of Contents
Frequently asked questions
-
Which is the leading segment in the Soft Tissue Biologics pipeline market?
Synthetic Graft is the leading segment in the Soft Tissue Biologics pipeline market as of August 2023.
-
Which territory has the highest number of pipeline products in the Soft Tissue Biologics pipeline market?
As of August 2023, the US has the highest number of products in the Soft Tissue Biologics pipeline market.
-
Which is the most followed regulatory pathway in the Soft Tissue Biologics pipeline market?
As of August 2023, 510(k) is the most followed pathway for products in the Soft Tissue Biologics pipeline market.
-
Who are the major companies operating in the Soft Tissue Biologics pipeline market?
Some of the key companies in the Soft Tissue Biologics pipeline market are Acuitive Technologies Inc, Anika Therapeutics Inc, BioGend Therapeutics Co Ltd, Colorado Therapeutics, LLC, Columbia University, Core Essence Orthopaedics, LLC, and Georgia Institute of Technology
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.